Background: Peripheral intravenous cannula (IVC) insertion is one of the most common invasive procedures performed in neonates. Studies have looked at reduction of the risk of IVC related injuries by elective replacement, but none have been performed in neonates.
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Background: Perinatal hypoxia-ischemia is associated with lasting developmental deficits in myelination of the cerebral white matter in preterm infants. While there is a growing appreciation that signalling through Toll-like receptors (TLRs) and activation of downstream inflammatory cascades may play a prominent role in white matter injury, our recent studies suggest that activation of the TLR7 pathway may afford protection. In the present study, we therefore examined the potential of the synthetic TLR7 agonist, Gardiquimod (GDQ) to improve electrophysiological recovery and ameliorate cell loss after an acute profound hypoxic-ischemic insult in preterm fetal sheep.
Methods: Fetal sheep at 0.7 gestation (day~103; term~145) received a continuous ICV infusion of GDQ (GDQ-occlusion, n=5) or vehicle (vehicle-occlusion, n=9; vehicle sham-occlusion, n=9) at a rate of 18.56 ug/minute for 3 h or saline endotoxin-free vehicle commencing 60 min following a 25 min umbilical cord occlusion. After 3 days recovery in utero, ewes were euthanised and brains perfusion fixed.
Results: GDQ administration improved survival of immature and mature oligodendrocytes (CNPase) and total oligodendrocytes (Oligo-2) within the periventricular and intragyral white matter (p<0.05) 72 h after occlusion. This occurred in association with a significant reduction (p< 0.05) in cellular apoptosis (Caspase-3) and astrogliosis (GFAP), and improved recovery of electroencephalogram power (EEG) and spectral edge frequency (SEF).
Conclusions: In conclusion, our studies provide the first evidence that in preterm fetal sheep therapeutic manipulation through TLR7 signalling following hypoxia-ischemia can reduce white matter injury and improve electrophysiological recovery, offering the potential to preserve myelination in a physiological manner. This group of anomalies contribute significantly to infant mortality and present both diagnostic and treatment challenges.
CRITICAL LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION IN NEW ZEALAND
Methods: We undertook a population-based review of infants and fetuses with LVOTO including all live-births and stillbirths or terminations from 20 weeks gestation in NZ between 2006 and 2014. This included hypoplastic left heart syndrome (HLHS), aortic arch obstruction (AAO) comprising of coarctation and interrupted aortic arch, and aortic valve anomalies (AVA). Cases were obtained from the National Cardiac Centre and the Perinatal and Maternal Mortality Review Committee.
Results: Of the 243 with critical LVOTO, there were 125 with HLHS, 112 with AAO and 6 with isolated AVA. The incidence of LVOTO was significantly higher among Europeans (0.59 per 1,000) cf M aori (0.31 per 1,000; p<0.001) and Pacifica (0.27 per 1,000; p=0.002). The male to female ratio was 1:0.7 (p=0.1). The prenatal detection rate of HLHS was 91.2% cf 30.3% for AAO and 33.3% for AVA. Pregnancy termination rates were 44% of total cases with HLHS, 1.8% for AAO and 0% for AVA. Termination was less common among M aori and Pacifica than in Europeans (p=0.01). Infant mortality among live-born infants where there was intention to treat was significantly lower for AAO (8/103, 7.8%) cf HLHS (18/41, 44%; p<0.001).
Conclusions: There are ethnic differences in the incidence and pregnancy outcome of LVOTO. HLHS carries a high infant mortality rate despite a high prenatal detection rate.
